The King's Fund

The King's Fund

The King's Fund was founded in 1897 as the Prince of Wales's Hospital Fund for London, raising money for London's voluntary hospitals. It now operates as an endowed charitable foundation with a singular focus: improving health and care in England through independent analysis, leadership development, and policy advocacy. The charity holds its endowment to generate income that sustains its operations, though it does not publicly disclose the fund's total size. Its President, King Charles III, has held that role since 1986, while Sarah Woolnough serves as Chief Executive and Lord Kakkar chairs the Board of Trustees. Rather than deploying capital as a traditional asset allocator into funds or direct deals, The King's Fund deploys intellectual and human capital into the architecture of the English health system. Its work spans producing major independent reports on NHS finances and workforce planning, running leadership courses for senior clinicians and managers, and convening cross-sector partners including NHS England. Its partnership with GlaxoSmithKline delivers the GSK IMPACT Awards, recognizing excellence in community health charities. The foundation's reach is geographically concentrated on England, though its policy research often becomes reference points for health systems globally. The charity's scale is organizational rather than financial in the asset-management sense. It employs a substantial research, policy, and events team at its headquarters at 11–13 Cavendish Square in London. Its work is directly adjacent to the operations of NHS England, and its influence is amplified by its proximity to Westminster and Whitehall. The organization does not operate a venture arm, make program-related investments, or manage external capital — a posture that distinguishes it from endowed foundations that function more like institutional limited partners. What separates The King's Fund structurally is its role as an honest-broker policy institution funded by a historic endowment, not membership dues or government contracts. Its independence from the NHS — despite being entirely focused on its improvement — allows it to publish critical analyses of government health policy without the constraints an operating charity or contractor might face. The endowment's governance under a Board chaired by Lord Kakkar, a surgeon, academic, and crossbench peer, embeds deep clinical and legislative expertise in its oversight structure.